Reference number : GC-WD-DEO-2020-2021-Q4-2065, amendment number : 5, agreement type : C, recipient legal name : Biomedical Commercialization Canada Inc., recipient country : CA, recipient province : MB, recipient city : Winnipeg, recipient postal code : R3B 0P4, program name english : Western Diversification Program, program name french : Programme diversification de l'Ouest, program purpose english : Promote economic development and diversification in western Canada; and advance the interests of western Canada in national policy, program and project development and implementation., program purpose french : Stimuler le développement et la diversification de l'économie dans l'Ouest canadien et faire avancer les intérêts de l'Ouest du Canada dans le cadre de l'élaboration et de la mise en œuvre des politiques, des programmes et des projets nationaux., agreement title english : 000015231, agreement title french : 000015231, agreement number : 000015231, agreement value : 1497375.0, agreement start date : 2018-11-23, agreement end date : 2023-03-31, description english : Facilitate western Canadian SME access to Chinese venture capital and medical markets, description french : Faciliter l'accès des PME de l'Ouest canadien au capital de risque et aux marchés médicaux de la Chine, expected results english : Western Canadian businesses are innovative., expected results french : Les entreprises de l'Ouest canadien sont novatrices., additional information english : nan, additional information french : nan, owner organization : wd-deo, owner organization title : Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada